Columbia Laboratories (CBRX)

Add to Watchlists
Create an Alert
6.551 -0.04  -0.59% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
CBRX Price Chart
View All Events

CBRX Events

Date Type Description
Mar 05 Misc Q4 2013 Columbia Laboratories, Inc Financial Results Conference Call
Mar 05 Earnings Q4 2013 Columbia Laboratories, Inc Financial Results. Estimate: 0.16.
Nov 07 Misc Cbrx Q3 2013 Financial Results Conference Call
Nov 07 Earnings Cbrx Q3 2013 Financial Results. Estimate: 0.16.
Aug 12 Misc Cbrx Conference Call: Acquisition of Molecular Profiles Ltd.
Aug 09 Splits Ratio: 1:8
Aug 07 Misc Cbrx Q2 2013 Financial Results Conference Call
Aug 07 Earnings Columbia Laboratories Reports Second Quarter 2013 Financial Results. Estimate: 0.02.
May 09 Misc Cbrx Q1 2013 Financial Results Conference Call
May 09 Earnings Olumbia Laboratories to Discuss First Quarter 2013 Financial Results on May 9. Estimate: 0.01.
View All Performance Charts

CBRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Columbia Laboratories is up 36.87% over the last year vs S&P 500 Total Return up 23.54%, Mylan up 67.45%, and Teva Pharmaceutical up 36.11%.

Get Quote for

Portfolio Strategies Featuring CBRX

Did Columbia Laboratories make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CBRX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Columbia Laboratories, Inc., is engaged in the business of developing, manufacturing and selling pharmaceutical products that utilize its proprietary bioadhesive drug delivery technologies to treat various medical conditions.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CBRX 6.551 -0.04 -0.59% 79.63M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.